ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Sinovac Biotech Ltd

Sinovac Biotech Ltd (SVA)

6.47
0.00
(0.00%)
Closed June 15 4:00PM
0.00
0.00
(0.00%)

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
6.47
Bid
6.47
Ask
6.46
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Market Cap
Previous Close
6.47
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
71,139,402
Dividend Yield
-
PE Ratio
-1.78
Earnings Per Share (EPS)
-3.63
Revenue
448.27M
Net Profit
-258.36M

About Sinovac Biotech Ltd

Sinovac Biotech Ltd is a biopharmaceutical company. The company focuses on the research, development, manufacturing, and commercialization of vaccines for infectious diseases. Its product portfolio includes vaccines against hepatitis A and B, seasonal influenza, H5N1 pandemic influenza (avian flu), ... Sinovac Biotech Ltd is a biopharmaceutical company. The company focuses on the research, development, manufacturing, and commercialization of vaccines for infectious diseases. Its product portfolio includes vaccines against hepatitis A and B, seasonal influenza, H5N1 pandemic influenza (avian flu), H1N1 influenza (swine flu), mumps, and canine rabies. The company also provides services for disease control and prevention, collaborating with the Chinese governments at the national, state, and local levels. It sells its vaccines in China, while also exploring growth opportunities in international markets. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
Headquarters
Saint John, Atg
Founded
1970
Sinovac Biotech Ltd is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker SVA. The last closing price for Sinovac Biotech was $6.47. Over the last year, Sinovac Biotech shares have traded in a share price range of $ 0.00 to $ 0.00.

Sinovac Biotech currently has 71,139,402 shares outstanding. The market capitalization of Sinovac Biotech is $460.27 million. Sinovac Biotech has a price to earnings ratio (PE ratio) of -1.78.

SVA Latest News

SINOVAC Reports Unaudited Second Half of 2023 Financial Results and Files 2023 Annual Report on Form 20-F

Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, has filed its 2023 annual report on Form 20-F with the U.S. Securities...

Sinovac Amends Shareholder Rights Plan

Sinovac Biotech Ltd. (“Sinovac” or the “Company”) (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today announced that its board of directors has amended its shareholder...

シノバック取締役会、一方的な部分公開買い付けを全会一致で退ける

取締役会は全会一致で、シノバック株主に対し、買付提案に基づく株式の買付に 応じない よう勧告する (ビジネスワイヤ) -- 中国のバイオ医薬品におけるリーディングプロバイダーであるシノバック・バイオテ...

Sinovac董事會一致反對Alternative Liquidity主動提出的部分公開收購方案

董事會一致懇請Sinovac股東 不要 接受該購買邀約出售股票 (美國商業資訊)-- 中國首屈一指的生物製藥產品供應商Sinovac Biotech Ltd.(納斯達克代號:SVA,以下簡稱「SINOVAC」或「該公司」)今天宣布該公司董事...

Le conseil d'administration de Sinovac rejette à l'unanimité une offre partielle non sollicitée

Le conseil d’administration recommande à l’unanimité aux actionnaires de Sinovac de NE PAS déposer leurs actions suite à l'offre de rachat Sinovac Biotech Ltd. (NASDAQ : SVA) (« SINOVAC » ou la «...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
KAVLKaival Brands Innovations Group Inc
$ 5.96
(338.24%)
70.99M
LRHCLa Rosa Holdings Corporation
$ 1.165
(90.61%)
40.6M
SVMHSRIVARU Holding Ltd
$ 0.227586
(49.24%)
276.03M
BRFHBarfresh Food Group Inc
$ 3.03
(38.36%)
247.31k
NNENano Nuclear Energy Inc
$ 9.37
(32.53%)
1.77M
NXLNexalin Technologies Inc
$ 0.89
(-35.52%)
3.93M
INABIN8bio Inc
$ 1.095
(-34.82%)
4.92M
QXOQXO Inc
$ 134.10
(-34.71%)
142.29k
GANXGain Therapeutics Inc
$ 1.24
(-34.39%)
3.09M
KYTXKyverna Therapeutics Inc
$ 9.52
(-34.07%)
4.31M
NVDANVIDIA Corporation
$ 131.88
(1.75%)
309.34M
SVMHSRIVARU Holding Ltd
$ 0.227586
(49.24%)
276.03M
KITTNauticus Robotics Inc
$ 0.1921
(19.69%)
165.83M
CRKNCrown Electrokinetics Corporation
$ 0.0582
(-21.35%)
136.77M
SQQQProShares UltraPro Short QQQ
$ 8.43
(-1.29%)
112.46M

SVA Discussion

View Posts
AlternativeLiquidity AlternativeLiquidity 5 months ago
Tender offer for Sinovac Shares:
https://www.sec.gov/Archives/edgar/data/1084201/000187041224000001/0001870412-24-000001-index.htm

Investor Letter:
https://www.sec.gov/Archives/edgar/data/1084201/000187041224000001/Exhibit_A3.htm

For investors that are sick of holding the shares, this might be a good opportunity to exit.

Annual reports and other public disclosures from the company are available here:

https://www.sec.gov/edgar/browse/?CIK=0001084201

👍️0
mick mick 5 months ago
https://www.otcmarkets.com/stock/SVA
👍️0
mick mick 6 months ago
https://www.otcmarkets.com/stock/SVA
👍️0
mick mick 7 months ago
https://www.otcmarkets.com/stock/SVA
👍️0
mick mick 7 months ago
https://www.otcmarkets.com/stock/SVA
👍️0
IHuser IHuser 8 months ago
imo... i guarantee my following will destroy this ticker....quickly...SVA

IHuser
👍️0
IHuser IHuser 8 months ago
imo... ya mick me and my boys own this market now.....gl...wont be a market soon~



IHuser
👍️0
mick mick 9 months ago
https://www.otcmarkets.com/stock/SVA
👍️0
mick mick 10 months ago
SVA
Sinovac Biotech Ltd
6.47
0.00 (0.00%)
Volume: -
👍️0
mick mick 11 months ago
SVA
Sinovac Biotech Ltd
6.47
0.00 (0.00%)
Volume:
👍️0
mick mick 12 months ago
SVA
Sinovac Biotech Ltd
6.47
0.00 (0.00%)
Volume: -
👍️0
mick mick 12 months ago
SVA
Sinovac Biotech Ltd
6.47
0.00 (0.00%)
Volume: -
👍️0
mick mick 1 year ago
Date

Event

January 28, 2020

SINOVAC established and launched a new COVID-19 vaccine research and development project

June 13, 2020

SINOVAC announced a Phase I/II clinical study of its new COVID-19 vaccine, showing the vaccine was safe and effective in producing neutralizing antibodies

February 16, 2021

Professor Lau Chak-sing, Convener of the Hong Kong Vaccine Advisory Expert Committee, announced the committee’s review of data for CoronaVac®. Results showed CoronaVac® benefits outweigh the risks. The committee recommended the vaccine to the government

February 19, 2021

Within 72 hours after the advisory committee's recommendation, the first batch of one million doses of CoronaVac® arrived in Hong Kong from Beijing. Hong Kong subsequently launched a large-scale COVID-19 vaccination program

June 2, 2022

CoronaVac® was validated by the World Health Organization’s Emergency Use List Procedure

February 20, 2022

SINOVAC Foundation donations to Hong Kong helped local communities in the fight against the COVID-19 pandemic

April 14, 2022

In cooperation with HKU and Gleneagles Hospital, SINOVAC’s inactivated COVID-19 vaccine (omicron variant) was approved for clinical trials in Hong Kong

August 4, 2022

Children between the ages of 6 months and 3 years old were eligible for receiving CoronaVac®. To help the public complete their vaccinations as soon as possible, Hong Kong had opened up multiple new vaccination centers.

December 16, 2022

CoronaVac® was fully registered in Hong Kong under the Pharmacy and Poisons Ordinance Cap 138. It is one of the first COVID-19 vaccines approved for official registration in Hong Kong

May 10, 2023

SINOVAC announced the supply of the inactivated COVID-19 vaccine CoronaVac® (original strain) to Hong Kong’s private market, with plans to donate free COVID-19 vaccines to children

[1] HKSAR news.gov.hk: Professor Lo Chung Mo’s Chinese article dated 15 Sept 2022. https://www.news.gov.hk/chi/2022/09/20220915/20220915_145920_647.html

About SINOVAC

Sinovac Biotech Ltd. (SINOVAC) is a China-based biopharmaceutical company that focuses on the R&D, manufacturing, and commercialization of vaccines that protect against human infectious diseases.

SINOVAC's product portfolio includes vaccines against COVID-19, enterovirus 71 (EV71) infected Hand-Foot-Mouth disease (HFMD), hepatitis A, varicella, influenza, poliomyelitis, pneumococcal disease, and mumps.

The COVID-19 vaccine, CoronaVac®, has been approved for use in more than 60 countries and regions worldwide. The hepatitis A vaccine, Healive®, passed WHO prequalification requirements in 2017. The EV71 vaccine, Inlive®, is an innovative vaccine under "Category 1 Preventative Biological Products" and was commercialized in China in 2016. In 2022, SINOVAC's Sabin-strain inactivated polio vaccine (sIPV) and varicella vaccine were prequalified by the WHO.

SINOVAC was the first company to be granted approval for its H1N1 influenza vaccine Panflu.1®, which has supplied the Chinese government's vaccination campaign and stockpiling program. The Company is also the only supplier of the H5N1 pandemic influenza vaccine, Panflu®, to the Chinese government stockpiling program.

SINOVAC continually dedicates itself to new vaccine R&D, with more combination vaccine products in its pipeline, and constantly explores global market opportunities. SINOVAC plans to conduct more extensive and in-depth trade and cooperation with additional countries, and business and industry organizations.

For more information, please see the Company’s website at www.sinovac.com.



View source version on businesswire.com: https://www.businesswire.com/news/home/20230510005485/en/

Sinovac Biotech Ltd.
PR Team
pr@sinovac.com
👍️0
mick mick 1 year ago
decrease in sales <> https://www.otcmarkets.com/filing/html?id=16605858&guid=_1T-knRCUJRXB3h
👍️0
mick mick 1 year ago
interesting review <> https://ih.advfn.com/stock-market/NASDAQ/sinovac-biotech-SVA/stock-news/91160230/amended-statement-of-beneficial-ownership-sc-13d-a

$SVA
👍️0
mick mick 1 year ago
Amended Statement of Beneficial Ownership (sc 13d/a) • Edgar (US Regulatory) • 05/25/2023 11:14:28 AM
CoronaVac® von SINOVAC erfüllt Hongkongs Bedarf an COVID-19-Impfstoffen zur Selbstzahlung • Business Wire • 05/12/2023 04:22:00 PM
??????CoronaVac ®????????????COVID-19????????????????? • Business Wire • 05/10/2023 06:02:00 PM
Le vaccin CoronaVac® de SINOVAC répond au besoin pour des vaccins contre la COVID-19 autopayés à Hong Kong • Business Wire • 05/10/2023 06:02:00 PM
👍️0
mick mick 1 year ago
SVA
Sinovac Biotech Ltd
6.47
0.00 (0.00%)
Volume:
👍️0
mick mick 1 year ago
SVA
Sinovac Biotech Ltd
6.47
0.00 (0.00%)
Volume:
👍️0
mick mick 1 year ago
Sinovac ändert Plan für Aktionärsrechte • Business Wire • 02/22/2023 03:20:00 PM
Amended Securities Registration (section 12(b)) (8-a12b/a) • Edgar (US Regulatory) • 02/22/2023 11:31:40 AM
👍️0
mick mick 1 year ago
Recent SVA News
???????????????? • Business Wire • 02/23/2023 12:38:00 PM
Sinovac modifie le régime de droits des actionnaires • Business Wire • 02/22/2023 05:02:00 PM
Sinovac ändert Plan für Aktionärsrechte • Business Wire • 02/22/2023 03:20:00 PM
Amended Securities Registration (section 12(b)) (8-a12b/a) • Edgar (US Regulatory) • 02/22/2023 11:31:40 AM
👍️0
mick mick 1 year ago
SVA
Sinovac Biotech Ltd
6.47
0.00 (0.00%)
Volume:
👍️0
mick mick 1 year ago
SVA
Sinovac Biotech Ltd
6.47
0.00 (0.00%)
Volume:
👍️0
mick mick 1 year ago
$SVA http://www.sinovac.com/
👍️0
mick mick 1 year ago
SINOVAC Reports Unaudited First Half of 2022 Financial ResultsBUSINESS WIRE | 12/29/2022
👍️0
mick mick 1 year ago
FORM TYPE RECEIVED PERIOD END DATE REPORT
6-K 12/29/2022 12/29/2022 PDFRTFHTMLXLS
SC 13D/A 12/12/2022 PDFRTFHTMLXLS
6-K 11/04/2022 11/04/2022 PDFRTFHTML
6-K 06/09/2022 06/09/2022 PDFRTFHTML
6-K 05/06/2022 05/06/2022 PDFRTFHTML
6-K 05/02/2022 04/29/2022 PDFRTFHTMLXLS
20-F 04/29/2022 12/31/2021 PDFRTFHTMLXLS
8-A12B/A 02/22/2022 PDFRTFHTMLXLS
6-K 02/22/2022 02/22/2022 PDFRTFHTML
6-K 12/30/2021 12/30/2021 PDFRTFHTMLXLS
👍️0
mick mick 1 year ago
SVA
Sinovac Biotech Ltd
6.47
0.00 (0.00%)
Volume: -
👍️0
mick mick 1 year ago
SVA
Sinovac Biotech Ltd
6.47
0.00 (0.00%)
Volume: -
👍️0
mick mick 1 year ago
SVA Latest News
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) 12/29/2022 08:41:47 AM
SINOVAC Reports Unaudited First Half of 2022 Financial Results 12/29/2022 08:30:00 AM
Amended Statement of Beneficial Ownership (sc 13d/a) 12/12/2022 06:45:09 AM
?????????????WHO???????? 11/04/2022 08:01:00 AM
👍️0
mick mick 1 year ago
https://www.otcmarkets.com/stock/SVA/security
👍️0
mick mick 1 year ago
SVA
Sinovac Biotech Ltd
6.47
0.00 (0.00%)
Volume:
👍️0
mick mick 1 year ago
https://www.otcmarkets.com/stock/SVA/disclosure
👍️0
mick mick 1 year ago
Recent SVA News
???????????????COVID-19????????????????????? • Business Wire • 09/07/2022 11:57:00 AM
SINOVAC erhält Genehmigung für klinische Studie zu seinem Omikron-COVID-19-Impfstoff in Chile • Business Wire • 09/06/2022 07:20:00 PM
SINOVAC autorisé à lancer au Chili un essai clinique pour son vaccin contre le variant Omicron du Covid-19 • Business Wire • 09/06/2022 02:03:00 PM
👍️0
mick mick 1 year ago
Recent SVA News
???????????????COVID-19????????????????????? • Business Wire • 09/07/2022 11:57:00 AM
SINOVAC erhält Genehmigung für klinische Studie zu seinem Omikron-COVID-19-Impfstoff in Chile • Business Wire • 09/06/2022 07:20:00 PM
SINOVAC autorisé à lancer au Chili un essai clinique pour son vaccin contre le variant Omicron du Covid-19 • Business Wire • 09/06/2022 02:03:00 PM
👍️0
mick mick 1 year ago
SVA
Sinovac Biotech Ltd
6.47
0.00 (0.00%)
👍️0
mick mick 2 years ago
Recent SVA News
???????????????COVID-19????????????????????? • Business Wire • 09/07/2022 11:57:00 AM
SINOVAC erhält Genehmigung für klinische Studie zu seinem Omikron-COVID-19-Impfstoff in Chile • Business Wire • 09/06/2022 07:20:00 PM
SINOVAC autorisé à lancer au Chili un essai clinique pour son vaccin contre le variant Omicron du Covid-19 • Business Wire • 09/06/2022 02:03:00 PM
👍️0
mick mick 2 years ago
https://www.nytimes.com/2020/12/25/health/turkey-brazil-sinovac-coronavirus-vaccine.html?source=content_type%3Areact%7Cfirst_level_url%3Aarticle%7Csection%3Amain_content%7Cbutton%3Abody_link
Turkey signed a deal with Sinovac for 50 million doses of the vaccine. The first three million doses are scheduled to arrive Monday in Turkey,
Mr. Koca said. Mr. Koca said Turkey would also get 4.5 million doses of the Pfizer-BioNTech vaccine by the end of March.
Around 1 million doses are expected to arrive at the end of January, he said.
👍️0
mick mick 2 years ago
Contact: Stella Wang
Email: http://www.Stellawang@1globe-china.com
👍️0
mick mick 2 years ago
Contact: Stella Wang
Email: http://www.Stellawang@1globe-china.com
👍️0
mick mick 2 years ago
http://www.sinovac@sinovac.com
👍️0
mick mick 2 years ago
http://www.pr@sinovac.com
👍️0
mick mick 2 years ago
Recent SVA News
??????COVID-19??????????6????????????????? • Business Wire • 08/05/2022 06:19:00 PM
L'utilisation du vaccin anti-COVID-19 de SINOVAC approuvée à partir de l'âge de six mois à Hong Kong • Business Wire • 08/03/2022 04:45:00 PM
COVID-19-Impfstoff von SINOVAC in Hongkong zur Verwendung bei Kindern ab einem Alter von 6 Monaten zugelassen • Business Wire • 08/03/2022 04:45:00 PM
SINOVAC COVID-19 Vaccine Approved for Use in Children Above 6 months of Age in Hong Kong • Business Wire • 08/03/2022 10:00:00 AM
?????????4???????????????????? • Business Wire • 07/20/2022 12:00:00 PM
SINOVAC startet klinische Studie für seinen Vierfach-Grippeimpfstoff in Chile • Business Wire • 07/19/2022 01:31:00 PM
SINOVAC lance un essai clinique au Chili pour son vaccin antigrippal quadrivalent • Business Wire • 07/19/2022 11:16:00 AM
👍️0
mick mick 2 years ago
SVA
Sinovac Biotech Ltd
6.47
0.00 (0.00%)
Volume: -
Bid: 6.93
Ask: 6.00
SVA Detailed Quote
👍️0
mick mick 2 years ago
SVA
Sinovac Biotech Ltd
6.47
0.00 (0.00%)
Volume: -
Bid: 6.93
Ask: 6.10
SVA Detailed Quote
👍️0
mick mick 2 years ago
https://www.otcmarkets.com/stock/SVA/overview
👍️0
mick mick 2 years ago
https://www.otcmarkets.com/stock/SVA/overview
👍️0
mick mick 2 years ago
never answered e-mail $SVA
👍️0
mick mick 2 years ago
yes hope it does $SVA
👍️0
mick mick 2 years ago
$SVA News: COVID-19-Impfstoff von SINOVAC erhält in Brasilien Notfallzulassung für Kinder im Alter von 3 bis 5 Jahren 07/14/2022 01:36:00 PM
SVA News: Le vaccin SINOVAC contre le COVID-19 est autorisé pour une utilisation d’urgence chez les enfants âgés de 3 à 5 ans au Brésil 07/14/2022 01:00:00 PM
👍️0
mick mick 2 years ago
$SVA News: SINOVAC COVID-19 Vaccine Is Authorized for Emergency Use in Kids Aged 3-5 In Brazil 07/14/2022 11:02:00 AM
👍️0
mick mick 2 years ago
$SVA News: SINOVAC COVID-19 Vaccine Is Authorized for Emergency Use in Kids Aged 3-5 In Brazil 07/14/2022 05:10:00 AM
SVA News: SINOVAC COVID-19 Vaccine Is Conditionally Registered In South Africa 06/25/2022 12:30:00 AM
👍️0

Your Recent History

Delayed Upgrade Clock